Using This Guide; Intended Use; Clinical Benefits; Intended Patient Population/Medical Conditions - ResMed AirFit N20 Guia Del Usuario

ENGLISH
Thank you for choosing the AirFit
masks are identical—except for the interchangeable AirFit F20
silicone cushion and AirTouch F20 foam cushion. This offers
two choices for your mask, depending on your preferred
comfort, stability and seal.
This document provides the user instructions for:
 ™ ™
AirFit F20/AirFit F20 for Her
 ™
AirTouch F20/AirTouch
These masks are referred to collectively as F20 throughout
this manual. These masks may not be available in all countries.

Using this guide

Please read the entire guide before use. When following
instructions, refer to the images at the front of the guide.

Intended use

The F20 is a non-invasive accessory used for channeling
airflow (with or without supplemental oxygen) to a patient
from a positive airway pressure (PAP) device such as a
continuous positive airway pressure (CPAP) or bilevel system.
The F20 is:

to be used by patients weighing more than 30 kg for
whom positive airway pressure therapy has been
prescribed

intended for single-patient reuse in the home environment
and multi-patient reuse in the hospital/institutional
environment.
™ ™
F20/AirTouch F20. These
™
F20 for Her
AirTouch F20 cushion
The cushion is intended for single-patient reuse in both home
and hospital/institutional environments and recommended to
be replaced monthly.
QuietAir elbow
The QuietAir elbow is intended for single-patient reuse in both
home and hospital/institutional environments.
WARNING
Magnets are used in the lower headgear straps and the
frame of the F20. Ensure the headgear and frame is kept at
least 50 mm away from any active medical implant (eg,
pacemaker or defibrillator) to avoid possible effects from
localized magnetic fields. The magnetic field strength is
less than 400 mT.

Clinical benefits

The clinical benefit of vented masks is the provision of
effective therapy delivery from a therapy device to the patient.
Intended patient population/medical
conditions
Obstructive pulmonary diseases (eg, Chronic Obstructive
Pulmonary Disease), restrictive pulmonary diseases (eg,
diseases of the lung parenchyma, diseases of the chest wall,
neuromuscular diseases), central respiratory regulation
diseases, obstructive sleep apnoea (OSA) and obesity
hypoventilation syndrome (OHS).
1